In news announced by the Australian Department of Health on November 7th, a joint operation conducted by the Australian Border Force (ABF) and the Therapeutic Goods Administration (TGA) has resulted in the seizure of over 35 tons of e-cigarette products suspected of containing nicotine.
The confiscated products were alleged to have been illegally imported and falsely labeled as "nicotine-free". However, laboratory tests conducted by the TGA revealed that the products did contain nicotine.
The Therapeutic Goods Administration (TGA) estimates that over 92%, or approximately 376,000, of e-cigarette products weighing over 35 tons are illegal, with a market value exceeding AUD 11 million.
The Therapeutic Goods Administration (TGA) has stated that at least 68% of the e-cigarettes in question are disposable, with the majority of them being brands previously found to violate the minimum safety and quality standards for nicotine e-cigarette products. In a laboratory test conducted by the TGA, 287 samples were examined, with 85% found to contain nicotine.
ABF and TGA are closely cooperating with states and territories to combat the illegal e-cigarette products in accordance with current regulatory laws.
Australian Health Minister Butler said, "I commend the TGA and ABF for removing a significant number of e-cigarettes from the Australian market, most importantly, removing them from the hands of young people in Australia.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
